Envoy Medical, Inc. (ticker: COCH) is an NASDAQ-listed clinical biotech company. DredgeCap's structured extraction of COCH's SEC filings surfaces 5 active risk signals, including 3 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. COCH reported $39K in revenue and -$4.35M for the period ending 2026-03-31, with operating cash flow of -$6.06M. Cash and equivalents stood at $25.25M (up 375.4% year-over-year). Total assets of $29.82M exceed total liabilities of $19.27M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
COCH Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Envoy Medical, Inc. (COCH) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.